scispace - formally typeset
H

Henry Masur

Researcher at National Institutes of Health

Publications -  414
Citations -  56261

Henry Masur is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Pneumocystis carinii & Pneumonia. The author has an hindex of 105, co-authored 402 publications receiving 52273 citations. Previous affiliations of Henry Masur include Burroughs Wellcome Fund & Memorial Sloan Kettering Cancer Center.

Papers
More filters
Journal ArticleDOI

HIV infection and cardiovascular disease--is there really a link?

TL;DR: Soon after the introduction of protease inhibitors and nonnucleoside reverse-transcriptase inhibitors for the management of human immunodeficiency virus (HIV) infection, clinicians observed unexpec...
Journal ArticleDOI

Induced sputum to diagnose Pneumocystis carinii pneumonia in immunosuppressed pediatric patients.

TL;DR: In summary abnormalities of neutrophil function develop in patients with ketosis induced by any of a variety of manipulations or disease states, and consideration should be given to discontinuing iatrogenic causes of ketosis in such patients if bacterial infections develop.
Journal ArticleDOI

Interferon-α Produces Significant Decreases in HIV Load

TL;DR: There was no significant difference among groups in change in total CD4(+) count or in time to AIDS or death, and since treatment with IFN-alpha produces significant decreases in HIV load, additional studies of IFn-alpha as part of a combination regimen are warranted.
Journal ArticleDOI

Sera from patients with the acquired immunodeficiency syndrome inhibit production of interleukin-2 by normal lymphocytes.

TL;DR: Sera from patients with the acquired immunodeficiency syndrome (AIDS) suppressed phytohemagglutinin (PHA)-induced IL-2 production by normal blood mononuclear cells and acted directly on the groups of cells that produce IL-1, T cells and large granular lymphocytes; suppression occurred at an early, probably pretranslational stage.
Journal ArticleDOI

Guide to Major Clinical Trials of Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients: Protease Inhibitors, Non-Nucleoside Reverse Transcriptase Inhibitors, and Nucleotide Reverse Transcriptase Inhibitors

TL;DR: The intent is to present a thorough, but not necessarily exhaustive, review of studies that have shaped the principles of antiretroviral therapy.